These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 38524132)
1. A novel type-2 innate lymphoid cell-based immunotherapy for cancer. Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA Front Immunol; 2024; 15():1317522. PubMed ID: 38524132 [TBL] [Abstract][Full Text] [Related]
2. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model. Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145 [TBL] [Abstract][Full Text] [Related]
3. The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice. Bahhar I; Eş Z; Köse O; Turna A; Günlüoğlu MZ; Çakır A; Duralı D; Magnusson FC Front Immunol; 2023; 14():1244437. PubMed ID: 37781372 [TBL] [Abstract][Full Text] [Related]
4. Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity. Yue J; Guo H; Xu P; Ma J; Shi W; Wu Y Cancer Immunol Immunother; 2024 Mar; 73(4):65. PubMed ID: 38430390 [TBL] [Abstract][Full Text] [Related]
5. Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice. LeSuer WE; Kienzl M; Ochkur SI; Schicho R; Doyle AD; Wright BL; Rank MA; Krupnick AS; Kita H; Jacobsen EA J Allergy Clin Immunol; 2023 Aug; 152(2):469-485.e10. PubMed ID: 37028525 [TBL] [Abstract][Full Text] [Related]
6. ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses. Topczewska PM; Rompe ZA; Jakob MO; Stamm A; Leclère PS; Preußer A; Duerr CU; Thole LML; Kotsch K; Artis D; Klose CSN Front Immunol; 2023; 14():1130933. PubMed ID: 37063913 [TBL] [Abstract][Full Text] [Related]
7. Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice. Drake LY; Iijima K; Kita H Allergy; 2014 Oct; 69(10):1300-7. PubMed ID: 24939388 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of Group 2 Innate Lymphoid Cells Defines Their Pleiotropic Roles in Cancer, Obesity, and Cardiovascular Diseases. Ikutani M; Nakae S Front Immunol; 2022; 13():939378. PubMed ID: 35844571 [TBL] [Abstract][Full Text] [Related]
11. Protein kinase Cθ controls type 2 innate lymphoid cell and T Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240 [TBL] [Abstract][Full Text] [Related]
12. IL-10 producing type 2 innate lymphoid cells prolong islet allograft survival. Huang Q; Ma X; Wang Y; Niu Z; Wang R; Yang F; Wu M; Liang G; Rong P; Wang H; Harris DC; Wang W; Cao Q EMBO Mol Med; 2020 Nov; 12(11):e12305. PubMed ID: 33034128 [TBL] [Abstract][Full Text] [Related]
13. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation. Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH Front Immunol; 2021; 12():664218. PubMed ID: 34867937 [TBL] [Abstract][Full Text] [Related]
14. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice. Symowski C; Voehringer D Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294 [TBL] [Abstract][Full Text] [Related]
15. Systemic administration of IL-33 induces a population of circulating KLRG1 Guillerey C; Stannard K; Chen J; Krumeich S; Miles K; Nakamura K; Smith J; Yu Y; Ng S; Harjunpää H; Teng MW; Engwerda C; Belz GT; Smyth MJ Immunol Cell Biol; 2021 Jan; 99(1):65-83. PubMed ID: 32748462 [TBL] [Abstract][Full Text] [Related]
16. Group 2 innate lymphoid cells boost CD8 Wen J; Cheng S; Wang R; Huang Y; Xu L; Ma L; Ling Z; Xu J; Zhao D; Zhang Y; Sun B Oncoimmunology; 2023; 12(1):2243112. PubMed ID: 37577145 [TBL] [Abstract][Full Text] [Related]
17. IL-33 and the PKA Pathway Regulate ILC2 Populations Expressing IL-9 and ST2. Olguín-Martínez E; Muñoz-Paleta O; Ruiz-Medina BE; Ramos-Balderas JL; Licona-Limón I; Licona-Limón P Front Immunol; 2022; 13():787713. PubMed ID: 35711429 [TBL] [Abstract][Full Text] [Related]
18. A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis. Neumann K; Karimi K; Meiners J; Voetlause R; Steinmann S; Dammermann W; Lüth S; Asghari F; Wegscheid C; Horst AK; Tiegs G J Immunol; 2017 Jan; 198(1):128-137. PubMed ID: 27872212 [TBL] [Abstract][Full Text] [Related]
19. ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8 Wan J; Wu Y; Huang L; Tian Y; Ji X; Abdelaziz MH; Cai W; Dineshkumar K; Lei Y; Yao S; Sun C; Su Z; Wang S; Xu H Cancer Lett; 2021 Apr; 502():34-43. PubMed ID: 33429004 [TBL] [Abstract][Full Text] [Related]
20. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis. Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562 [No Abstract] [Full Text] [Related] [Next] [New Search]